TGF-β1 has been shown to play a critical pathogenic role in diabetes-associated myocardial fibrosis by activating Smads-dependent signals in diabetic mice, leading to pathological fibrosis (32–38). This evidence concerns the gene TGFB1 and diabetes mellitus.